Regeneron Pharmaceuticals... (REGN)
undefined
undefined%
At close: undefined
731.30
0.08%
After-hours Dec 13, 2024, 05:19 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97 FY96 FY95 FY94 FY93 FY92 FY91
Net Income 3.95B 4.34B 8.08B 3.51B 2.12B 2.44B 1.20B 895.52M 636.06M 348.07M 424.36M 750.27M -221.76M -104.47M -67.83M -82.71M -105.60M -102.34M -95.45M 41.70M -107.46M -124.38M -76.18M -23.21M -23.10M -8.60M -11.60M -32.40M -23.50M -30.70M -39.90M -19.10M -4.50M
Depreciation & Amortization 421.00M 341.40M 286.20M 235.90M 210.30M 148.20M 145.47M 104.75M 74.91M 52.69M 41.20M 36.94M 31.08M 19.69M 14.25M 11.29M 11.49M 14.59M 15.50M 15.36M 12.94M 8.45M 6.08M 4.42M 3.40M 3.00M 4.40M 6.10M 5.90M 4.20M 3.10M 2.00M 800.00K
Stock-Based Compensation 885.00M 725.00M 601.70M 432.00M 464.30M 427.40M 507.28M 559.88M 459.05M 307.24M 198.40M 94.16M 56.09M 39.90M 31.26M 32.52M - - - - - - - - - - - - - - - - -
Other Working Capital -82.20M -116.20M -360.90M 263.00M 163.60M -250.20M -226.43M 267.81M 529.42M -18.66M -80.74M -41.08M 3.65M 168.48M -27.50M -35.54M 87.47M 89.36M 26.54M -65.66M 85.38M 5.31M 11.96M -19.30M 5.20M -7.40M -2.60M -8.50M -14.80M - - - -
Other Non-Cash Items 266.30M 599.80M 181.70M -135.00M -29.30M 12.10M -36.90M 485.70M 619.82M 361.62M 133.65M -861.82M 10.37M 293.00K -382.00K 2.25M 34.02M 17.86M 21.86M -15.23M 4.06M 1.82M 1.77M 6.14M 4.70M 2.80M 3.70M 14.50M 14.20M 9.00M 3.60M -1.60M -2.50M
Deferred Income Tax -837.80M -746.40M -147.10M 75.60M -130.60M -140.00M 318.81M -360.08M -121.62M -66.60M 63.60M -340.16M - - -56.00K - - - - - - - - - - - - - - - - - -
Change in Working Capital -94.10M -243.30M -1.92B -1.50B -200.50M -697.00M -926.53M 228.19M 229.83M 20.24M -190.67M -672.80M -17.46M 140.94M -49.47M -52.43M 87.47M 92.96M 27.79M -58.74M 84.33M 3.58M 11.02M -15.25M 1.20M -7.40M -2.60M -8.50M -14.80M -3.00M 3.10M 1.50M -600.00K
Operating Cash Flow 4.59B 5.01B 7.08B 2.62B 2.43B 2.20B 1.31B 1.49B 1.33B 752.43M 588.60M -74.61M -141.68M 96.34M -72.23M -89.09M 27.37M 23.07M -30.30M -16.91M -6.13M -110.52M -57.32M -27.91M -13.80M -10.20M -6.10M -20.30M -18.20M -20.50M -30.10M -17.20M -6.80M
Capital Expenditures -926.40M -590.10M -551.90M -614.60M -429.60M -383.10M -272.60M -511.90M -677.93M -333.01M -156.32M -49.34M -57.22M -99.69M -97.32M -34.86M -18.45M -2.81M -4.96M -6.17M -29.66M -34.37M -8.22M -6.50M -5.70M -3.00M -2.10M -8.60M -3.30M -6.90M -10.20M -2.10M -1.00M
Acquisitions -54.90M -230.30M 551.90M 614.60M 429.60M 1.07B - - - - - - - - - - - - - - - - - - - - - - - - - - -
Purchase of Investments -11.65B -7.49B -7.05B -3.24B -3.20B -1.85B -1.28B -809.42M -557.11M -564.19M -577.28M -470.39M -240.39M -612.19M -200.00M -581.14M -594.45M -456.89M -102.99M -276.32M -287.50M -239.98M -191.35M -104.90M -60.10M -88.00M -112.60M -74.60M -28.10M -22.50M -77.30M -71.60M -137.20M
Sales Maturities Of Investments 9.44B 5.55B 2.22B 3.79B 1.60B 775.60M 544.58M 274.46M 327.44M 476.42M 378.15M 439.21M 426.36M 276.60M 297.41M 646.86M 527.17M 306.20M 223.45M 277.91M 253.31M 215.83M 124.19M 53.72M 83.20M 93.50M 75.90M 38.90M 38.80M 61.30M 68.50M 82.80M 61.80M
Other Investing Acitivies -926.40M -1.03B -551.90M -614.60M -429.60M -1.08B -732.60M -534.90M -229.67M -87.77M -199.13M -31.74M -277.00K 1.12M 50.00K -50.00K - -1.60M - - - - - - 100.00K -100.00K -100.00K - - - -4.60M -900.00K -1.20M
Investing Cash Flow -3.19B -3.78B -5.38B -70.60M -2.03B -1.46B -1.01B -1.05B -907.60M -420.78M -355.45M -81.07M 128.47M -434.15M 146.00K 30.82M -85.72M -155.10M 115.49M -4.58M -63.84M -58.52M -75.39M -57.68M 17.50M 2.40M -38.90M -44.30M 7.40M 31.90M -23.60M 8.20M -77.60M
Debt Repayment - - - 1.98B - - 37.10M -40.60M -140.45M -221.73M -2.02M -2.20M 389.44M 46.52M 22.77M -200.81M - - - 3.83M 13.51M -426.00K 190.60M -1.50M -1.10M -1.90M -3.90M -3.70M -3.30M -300.00K -1.20M -800.00K -100.00K
Common Stock Repurchased -2.94B -2.53B -2.68B -6.53B -463.90M -191.60M -301.70M -143.20M -160.54M -267.58M -195.09M -163.30M -25.08M -3.80M - - - - - -888.00K - - - - - - - - - - - - -
Dividend Paid - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Financial Acitivies - - - - - - - -643.29M -168.17M 154.00M 216.86M 4.31M -23.70M - - - - 390.00K - - - - - - - - -100.00K - - 100.00K -100.00K - -
Financial Cash Flow -1.79B -1.01B -1.01B -1.97B -252.10M -77.10M -24.40M -700.39M -262.80M -209.27M 77.14M -97.65M 384.25M 243.31M 31.36M -192.86M 319.40M 185.40M 4.08M 4.44M 108.18M 1.72M 349.12M 92.87M 300.00K -1.40M 39.40M 66.30M 19.90M -200.00K 49.80M -800.00K 91.50M
Net Cash Flow -381.60M 221.30M 690.80M 577.00M 150.10M 655.00M 277.53M -273.90M 160.38M 113.11M 305.33M -253.33M 371.04M -94.50M -40.72M -251.13M 261.05M 53.37M 89.28M -17.05M 38.21M -167.32M 216.41M 7.28M 3.90M -9.20M -5.60M 1.70M 9.10M 11.20M -3.90M -9.80M 7.10M
Free Cash Flow 3.67B 4.42B 6.53B 2.00B 2.00B 1.81B 1.03B 974.00M 652.85M 419.43M 432.27M -123.95M -198.90M -3.35M -169.55M -123.94M 8.93M 20.26M -35.26M -23.08M -35.79M -144.89M -65.54M -34.41M -19.50M -13.20M -8.20M -28.90M -21.50M -27.40M -40.30M -19.30M -7.80M